RXRan Xiong

Ran Xiong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ran Xiong has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Mingran Xie

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

    5 shared publications
  • Han‐Ran Wu

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    4 shared publications
  • Guang‐Wen Xu

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    2 shared publications
  • Mei‐Qing Xu

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    2 shared publications
  • Shi‐Bin Xu

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    2 shared publications
  • Cai‐Wei Li

    Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    1 shared publication

Latest Publications

  • Open Access

    Comparison of short‐term outcomes following minimally invasive versus open Sweet esophagectomy for Siewert type II adenocarcinoma of the esophagogastric junction

    by Xiaohui Sun, Gaoxiang Wang, Changqing Liu, Ran Xiong, Hanran Wu, Mingran Xie, Shibin Xu

    Background: Surgical resection is still the main treatment option for patients with resectable Siewert type II adenocarcinoma of the esophagogastric junction (AEG). This retrospective study evaluated the significance of minimally invasive Sweet esophagectomy (MISE) for the treatment of Siewert type II AEG.Methods: We retrospectively evaluated 174 patients with Siewert type II AEG who received a Sweet esophagectomy in our center between October 2013 and September 2017. Of these patients, 73 underwent MISE and 101 underwent open Sweet esophagectomy (OSE). The clinicopathologic factors, operational factors and postoperative complications were compared.Results: The two groups were similar in terms of age, sex, American Society of Anesthesiologists grade, preoperative staging and incidence of comorbidities (P > 0.05). Relative to the OSE approach, the MISE approach was associated with a significant decrease in surgical blood loss (P < 0.001), chest tube duration (P = 0.003) and postoperative admission duration (P = 0.002). The minimally invasive approach was associated with significantly less total morbidity and fewer respiratory complications than the open approach (P = 0.015 and P = 0.016, respectively). Relative to the open approach, the MISE approach was associated with a significant increase in the number of total lymph nodes removed and the locations of the total lymph nodes removed (P < 0.001 and P < 0.001, respectively).Conclusions: Our MISE technique can be safely and effectively performed for intrathoracic anastomosis with favorable early outcomes.


  • Open Access

    Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus

    by Gaoxiang Wang, Xuejiao Li, Ran Xiong, Hanran Wu, Meiqing Xu, Mingran Xie

    Background: This study aimed to investigate the effect of type 2 diabetes mellitus on survival of patients with non‐small cell lung cancer (NSCLC).Methods: We retrospectively analyzed NSCLC patients who had undergone radical lung cancer surgery from January 2011 to December 2014 in the Anhui Medical University affiliated Anhui Provincial Hospital. Kaplan‐Meier plots, log‐rank tests, and Cox proportional hazards regression models were used to describe the effect of type 2 diabetes mellitus on the overall survival of patients with NSCLC.Results: A total of 769 patients with NSCLC were enrolled, including 126 in the diabetic mellitus group and 643 in the nondiabetic mellitus group. The one, three, and five‐year survival for patients with and without diabetes mellitus were 86.1% versus 89.6%, 49.5% versus 62.4%, and 33.3% versus 40.6%, respectively. The Cox model showed that type 2 diabetes mellitus was a poor independent prognostic factors for NSCLC patients. In addition, metformin is a good independent prognostic factor for patients with non‐small cell lung cancer with type 2 diabetes mellitus.Conclusions: NSCLC patients without type 2 diabetes mellitus have an increased survival rate compared with those with type 2 diabetes mellitus.


  • Open Access

    A prospective study examining the impact of uniportal video‐assisted thoracic surgery on the short‐term quality of life in patients with lung cancer

    by Guang‐Wen Xu, Ming‐Ran Xie, Han‐Ran Wu, Ran Xiong, Cai‐Wei Li, Shi‐Bin Xu, Mei‐Qing Xu, Tian Li

    Background: The aim of this study was to evaluate the effect of uniportal and three‐portal VATS in lung cancer patients on the postoperative short‐term quality of life (QOL).Methods: A single‐center, prospective, nonrandomized study was performed on patients who underwent uniportal or three‐portal video‐assisted thoracoscopic surgery (VATS) lobectomy and systemic mediastinal lymph node dissection. QOL was measured before surgery at baseline and at one, two, four, and eight weeks after the operation. The measured data of normal distribution were indicated by the mean ± standard deviation, the independent sample t‐test was used among the groups, and the χ2 test was used to compare the counting. Non‐normal distribution of the measurement data was carried out using the Mann‐Whitney test.Results: Preoperative functional areas, symptom areas and overall health scores were similar in the two groups. The physical, role, emotional and social functions and overall health status of the uniportal group were significantly higher than those of the three‐portal group in postoperative time. The score of symptom field was higher in one week after operation, the score of two, four and eight weeks decreased gradually, but it was still above the preoperative level, and the fatigue and pain of the uniportal group were significantly lower than that of the three‐portal group.Conclusion: The advantages of uniportal VATS include a shorter hospital stay, more rapid recovery and superior cosmetic results compared to three‐portal VATS. Additionally, uniportal VATS is superior to three‐portal thoracoscopic surgery in terms of the immediate postoperative short‐term QOL.


  • Open Access

    Mechanism research of miR‐34a regulates Axl in non‐small‐cell lung cancer with gefitinib‐acquired resistance

    by Ran Xiong, Xiang‐Xiang Sun, Han‐Ran Wu, Guang‐Wen Xu, Gao‐Xiang Wang, Xiao‐Hui Sun, Mei‐Qing Xu, Ming‐Ran Xie

    Background: To investigate the regulatory mechanism behind miR‐34a‐altered Axl levels in non‐small‐cell lung cancer (NSCLC) with gefitinib‐acquired resistance.Methods: The expression of miR‐34a, Axl, Gas6 and related downstream signaling proteins in the EGFR mutant NSCLC cell lines were determined by qRT‐PCR and Western blot; PC9‐Gef‐miR‐34a and HCC827‐Gef‐miR‐34a cells were established by transfecting the parent cells with a miR‐34a overexpressing virus, then the expression of Axl, Gas6 and the downstream channel‐related proteins were also compared in PC9‐Gef‐miR‐34a and HCC827‐Gef‐miR‐34a and drug‐resistant strains. The survival rate of the cells were measured by CCK8 assay. A luciferase reporter detected whether Axl was the target of miR‐34a. Finally, a tumor‐bearing nude mouse model was established to verify the relationship between the expression of miR‐34a, Axl and Gas6 mRNA in vivo.Results: The expression levels of Axl mRNA and protein, Gas6 mRNA and protein, and related downstream proteins in PC9‐Gef and HCC827‐Gef cell lines were higher than those in PC9 and HCC827 parental cell lines, while the expression of miR‐34a was lower than it was in the parental cell lines (P < 0.05). The expression of Axl mRNA and protein, Gas6 mRNA and protein, and related downstream signaling proteins in PC9‐Gef and HCC827‐Gef cell lines was higher than the expression in PC9‐Gef‐miR‐34a and HCC827‐Gef‐miR‐34a cells, which overexpressed miR‐34a (P < 0.05).Conclusion: The miR‐34a regulation of Axl plays an important role in NSCLC‐acquired gefitinib resistance, and their expression is inversely correlated, which suggests that they can be used as prognostic markers or potential therapeutic targets for NSCLC.


  • Open Access

    Increased expression of TRPV1 in patients with acute or chronic cough after lung cancer surgery

    by Yong‐Fu Zhu, Sheng‐Bing Wu, Mei‐Qi Zhou, Ming‐Ran Xie, Ran Xiong, Shi‐Bin Xu, Guang‐Wen Xu

    Background: We investigated preoperative and postoperative TRPV1, bradykinin (BK), and prostaglandin e‐2 (PGE2) levels in patients who underwent lung cancer surgery and evaluated the correlations between these levels and the development of acute or chronic cough after surgery. Methods: We evaluated 60 patients with non‐small cell lung cancer who underwent lobectomy at our center between August and October 2018. TRPV1, BK, and PGE2 levels were determined by enzyme‐linked immunosorbent assay and postoperative cough was assessed using the visual analog scale (VAS). Results: The postoperative serum TRPV1, BK, and PEG2 levels of the 60 patients were significantly higher than the preoperative levels ( P < 0.001). Thirty‐five patients (58.3%) were diagnosed with acute cough (VAS ≥ 60 mm), and 25 were diagnosed with non‐acute cough (41.7%). Three days after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the acute cough group than in the non‐acute cough group ( P < 0.001). Twenty‐two patients (36.7%) were diagnosed with chronic cough (VAS ≥ 60 mm), and 25 (62.3%) were diagnosed with non‐chronic cough. Eight weeks after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the chronic cough group than in the non‐chronic cough group ( P < 0.05). Conclusions: The postoperative TRPV1, BK and PGE2 levels were significantly higher than the preoperative levels. The TRPV1 level was also higher in patients with an acute or chronic cough than in patients without. Postoperative acute or chronic cough symptoms can be improved and alleviated by blocking the TRPV1 pathway.